The choice of in-hospital or home administration for plerixafor injection to poor mobilizers has no adverse consequence on subsequent hematopoietic stem cell harvest

Bone Marrow Transplant. 2017 Aug;52(8):1212-1214. doi: 10.1038/bmt.2017.103. Epub 2017 Jun 5.
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autografts
  • Benzylamines
  • Cyclams
  • Hematologic Neoplasms* / blood
  • Hematologic Neoplasms* / therapy
  • Hematopoietic Stem Cell Mobilization*
  • Hematopoietic Stem Cells*
  • Heterocyclic Compounds / administration & dosage*
  • Home Care Services*
  • Peripheral Blood Stem Cell Transplantation*
  • Product Surveillance, Postmarketing
  • Registries

Substances

  • Benzylamines
  • Cyclams
  • Heterocyclic Compounds
  • plerixafor